PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024 16:03 ET
|
PacBio
MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will...
PacBio Announces Second Quarter 2024 Financial Results
August 07, 2024 16:05 ET
|
PacBio
MENLO PARK, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2024. Second quarter results: Revenue of $36.0 million...
Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia
August 05, 2024 16:05 ET
|
PacBio
SINGAPORE, Aug. 05, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore...
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
July 23, 2024 09:05 ET
|
PacBio
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its...
PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024
July 15, 2024 16:03 ET
|
PacBio
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results on...
PacBio Grants Equity Incentive Award to New Employee
June 27, 2022 20:00 ET
|
PacBio
MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows
May 08, 2022 19:00 ET
|
PacBio
MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with...
パックバイオ (PacBio)、iLACおよびロボティック･バイオロジー･インスティテュート株式会社 (Robotic Biology Institute) と共同で自動化ワークフローを開発
May 08, 2022 19:00 ET
|
Pacific Biosciences of California, Inc.
カリフォルニア州メンローパークおよび東京発, May 09, 2022 (GLOBE NEWSWIRE) -- 高品質･高精度のシーケンシングソリューションのリーディングカンパニーであるパックバイオ (PacBio) (NASDAQ: PACB) は、ゲノム解析企業である株式会社アイラック (iLAC, Inc.)、およびロボティック･バイオロジー･インスティテュート株式会社 (Robotic...
PacBio to Participate in the BofA Securities 2022 Healthcare Conference
May 05, 2022 16:10 ET
|
PacBio
MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s...
PacBio Announces First Quarter 2022 Financial Results
May 04, 2022 16:03 ET
|
PacBio
MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million, a...